Royce & Associates’s Healthcare Services Group HCSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55M Buy
2,239,224
+95,987
+4% +$2.03M 0.44% 41
2026
Q1
$39.8M Sell
2,143,237
-149,658
-7% -$2.95M 0.39% 58
2025
Q4
$43.8M Sell
2,292,895
-572,102
-20% -$10.3M 0.44% 43
2025
Q3
$48.2M Sell
2,864,997
-170,127
-6% -$2.53M 0.48% 34
2025
Q2
$45.6M Sell
3,035,124
-1,648,914
-35% -$21.9M 0.47% 41
2025
Q1
$47.2M Buy
4,684,038
+15,439
+0.3% +$169K 0.51% 33
2024
Q4
$54.2M Buy
4,668,599
+219,103
+5% +$2.5M 0.5% 39
2024
Q3
$49.7M Buy
4,449,496
+290,621
+7% +$3.19M 0.45% 46
2024
Q2
$44M Buy
4,158,875
+2,541
+0.1% +$28.2K 0.41% 52
2024
Q1
$51.9M Buy
4,156,334
+242,127
+6% +$2.68M 0.46% 43
2023
Q4
$40.6M Buy
3,914,207
+534,791
+16% +$5.34M 0.37% 63
2023
Q3
$35.2M Buy
3,379,416
+1,081,641
+47% +$13.5M 0.36% 63
2023
Q2
$34.3M Buy
2,297,775
+467,368
+26% +$6.77M 0.33% 66
2023
Q1
$25.4M Buy
1,830,407
+440,606
+32% +$5.8M 0.25% 99
2022
Q4
$16.7M Sell
1,389,801
-246,428
-15% -$3.25M 0.18% 156
2022
Q3
$19.8M Sell
1,636,229
-445,865
-21% -$6.57M 0.22% 113
2022
Q2
$36.2M Buy
2,082,094
+487,843
+31% +$8.41M 0.37% 55
2022
Q1
$29.6M Buy
1,594,251
+899,037
+129% +$15.5M 0.25% 92
2021
Q4
$12.4M Sell
695,214
-440,103
-39% -$8.56M 0.09% 350
2021
Q3
$28.4M Buy
1,135,317
+9,418
+0.8% +$255K 0.21% 127
2021
Q2
$35.5M Buy
1,125,899
+4,405
+0.4% +$134K 0.24% 100
2021
Q1
$31.4M Buy
1,121,494
+24,168
+2% +$730K 0.21% 134
2020
Q4
$30.8M Buy
1,097,326
+493,925
+82% +$11.9M 0.25% 96
2020
Q3
$13M Buy
603,401
+184,126
+44% +$4.3M 0.14% 208
2020
Q2
$10.3M Buy
419,275
+253,291
+153% +$6M 0.11% 261
2020
Q1
$3.97M Sell
165,984
-237
-0.1% -$6.09K 0.05% 441
2019
Q4
$4.04M Buy
166,221
+1,565
+1% +$38.8K 0.04% 542
2019
Q3
$4M Hold
164,656
0.04% 533
2019
Q2
$4.99M Hold
164,656
0.05% 490
2019
Q1
$5.43M Hold
164,656
0.05% 492
2018
Q4
$6.62M Sell
164,656
-4,076
-2% -$172K 0.06% 438
2018
Q3
$6.85M Hold
168,732
0.05% 499
2018
Q2
$7.29M Hold
168,732
0.05% 482
2018
Q1
$7.34M Sell
168,732
-21,400
-11% -$1.05M 0.05% 467
2017
Q4
$10M Sell
190,132
-29,568
-13% -$1.55M 0.07% 396
2017
Q3
$11.9M Sell
219,700
-16,200
-7% -$833K 0.08% 339
2017
Q2
$11M Sell
235,900
-9,800
-4% -$453K 0.07% 367
2017
Q1
$10.6M Hold
245,700
0.07% 371
2016
Q4
$9.62M Sell
245,700
-79,764
-25% -$3.05M 0.06% 394
2016
Q3
$12.9M Hold
325,464
0.08% 313
2016
Q2
$13.5M Hold
325,464
0.09% 299
2016
Q1
$12M Sell
325,464
-104,300
-24% -$3.62M 0.08% 346
2015
Q4
$15M Sell
429,764
-87,500
-17% -$3.18M 0.09% 303
2015
Q3
$17.4M Sell
517,264
-144,475
-22% -$4.88M 0.09% 268
2015
Q2
$21.9M Sell
661,739
-116,900
-15% -$3.68M 0.09% 277
2015
Q1
$25M Sell
778,639
-114,500
-13% -$3.7M 0.09% 274
2014
Q4
$27.6M Sell
893,139
-3,900
-0.4% -$116K 0.1% 269
2014
Q3
$25.7M Sell
897,039
-21,100
-2% -$587K 0.09% 282
2014
Q2
$27M Sell
918,139
-7,700
-0.8% -$227K 0.08% 303
2014
Q1
$26.9M Buy
925,839
+107,200
+13% +$2.94M 0.08% 301
2013
Q4
$23.2M Buy
818,639
+17,100
+2% +$468K 0.07% 349
2013
Q3
$20.6M Buy
801,539
+15,500
+2% +$388K 0.06% 367
2013
Q2
$19.3M Buy
+786,039
New +$18.1M 0.06% 366

Other funds holding HCSG

Royce & Associates's HCSG Position: Q2 2026 in Review

Royce & Associates increased its Healthcare Services Group (HCSG) stake by 4.5% in Q2 2026, buying an estimated $2.03M and bringing the position to 2,239,224 shares worth $55M. The position accounts for 0.44% of the portfolio, ranked #41.

Royce & Associates first reported a position in HCSG in Q2 2013 and has held it in 53 quarters since. 274 funds tracked by Wall St. Rank hold HCSG as of Q2 2026.

  • Royce & Associates held 2,239,224 shares of Healthcare Services Group worth $55M as of Q2 2026.
  • Royce & Associates bought 95,987 Healthcare Services Group shares in Q2 2026, an estimated $2.03M.
  • Healthcare Services Group made up 0.44% of Royce & Associates's portfolio in Q2 2026, its #41 holding.
  • Royce & Associates first reported a position in Healthcare Services Group in Q2 2013 and has held it in 53 quarters since.
  • 274 funds tracked by Wall St. Rank held Healthcare Services Group as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.